PMID- 24362110 OWN - NLM STAT- MEDLINE DCOM- 20141014 LR - 20140210 IS - 1879-0712 (Electronic) IS - 0014-2999 (Linking) VI - 724 DP - 2014 Feb 5 TI - Inhibitors of arachidonate-regulated calcium channel signaling suppress triggered activity induced by the late sodium current. PG - 92-101 LID - S0014-2999(13)00948-5 [pii] LID - 10.1016/j.ejphar.2013.12.020 [doi] AB - Disturbances in myocyte calcium homeostasis are hypothesized to be one cause for cardiac arrhythmia. The full development of this hypothesis requires (i) the identification of all sources of arrhythmogenic calcium and (ii) an understanding of the mechanism(s) through which calcium initiates arrhythmia. To these ends we superfused rat left atria with the late sodium current activator type II Anemonia sulcata toxin (ATXII). This toxin prolonged atrial action potentials, induced early afterdepolarization, and provoked triggered activity. The calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93 (N-[2-[[[3-(4-chlorophenyl)-2-propenyl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulphon-amide) suppressed ATXII triggered activity but its inactive congener KN-92 (2-[N-(4-methoxy benzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine) did not. Neither drug affected normal atrial contractility. Calcium entry via L-type channels or calcium leakage from sarcoplasmic reticulum stores are not critical for this type of ectopy as neither verapamil ((RS)-2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl]-(methyl)amino-2-prop-2-ylpentanenitrile) nor ryanodine affected ATXII triggered activity. By contrast, inhibitors of the voltage independent arachidonate-regulated calcium (ARC) channel and the store-operated calcium channel specifically suppressed ATXII triggered activity without normalizing action potentials or affecting atrial contractility. Inhibitors of cytosolic calcium-dependent phospholipase A2 also suppressed triggered activity suggesting that this lipase, which generates free arachidonate, plays a key role in ATXII ectopy. Thus, increased left atrial late sodium current appears to activate atrial Orai-linked ARC and store operated calcium channels, and these voltage-independent channels may be unexpected sources for the arrhythmogenic calcium that underlies triggered activity. CI - Copyright (c) 2013 Elsevier B.V. All rights reserved. FAU - Wolkowicz, Paul AU - Wolkowicz P AD - KOR Therapies, LLC, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: kor.cures@gmail.com. FAU - Umeda, Patrick K AU - Umeda PK AD - The Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. FAU - Sharifov, Oleg F AU - Sharifov OF AD - The Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. FAU - White, C Roger AU - White CR AD - The Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. FAU - Huang, Jian AU - Huang J AD - The Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. FAU - Mahtani, Harry AU - Mahtani H AD - The Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. FAU - Urthaler, Ferdinand AU - Urthaler F AD - The Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131219 PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (Benzylamines) RN - 0 (Calcium Channels) RN - 0 (Cardiotonic Agents) RN - 0 (Cnidarian Venoms) RN - 0 (Phospholipase A2 Inhibitors) RN - 0 (Sulfonamides) RN - 139298-40-1 (KN 93) RN - 27YG812J1I (Arachidonic Acid) RN - 60748-45-0 (toxin II (Anemonia sulcata)) RN - 9NEZ333N27 (Sodium) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - EC 3.1.1.4 (Group IV Phospholipases A2) RN - EC 3.1.1.4 (Pla2g4a protein, rat) SB - IM MH - Animals MH - Arachidonic Acid/physiology MH - Atrial Function/*drug effects MH - Benzylamines/pharmacology MH - Calcium Channels/*physiology MH - Calcium Signaling MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2/antagonists & inhibitors/metabolism MH - Cardiotonic Agents/*pharmacology MH - Cnidarian Venoms/*pharmacology MH - Group IV Phospholipases A2/antagonists & inhibitors MH - Heart Atria/*drug effects MH - Phospholipase A2 Inhibitors/pharmacology MH - Rats MH - Sodium/*physiology MH - Sulfonamides/pharmacology OTO - NOTNLM OT - ARC channel OT - ATXII OT - Early afterdepolarization OT - LOE-908 OT - Late sodium current OT - Orai OT - SKF-96365 OT - Store operated calcium channel OT - Triggered activity EDAT- 2013/12/24 06:00 MHDA- 2014/10/15 06:00 CRDT- 2013/12/24 06:00 PHST- 2013/05/20 00:00 [received] PHST- 2013/12/11 00:00 [revised] PHST- 2013/12/12 00:00 [accepted] PHST- 2013/12/24 06:00 [entrez] PHST- 2013/12/24 06:00 [pubmed] PHST- 2014/10/15 06:00 [medline] AID - S0014-2999(13)00948-5 [pii] AID - 10.1016/j.ejphar.2013.12.020 [doi] PST - ppublish SO - Eur J Pharmacol. 2014 Feb 5;724:92-101. doi: 10.1016/j.ejphar.2013.12.020. Epub 2013 Dec 19.